Literature DB >> 28616313

MYCing and YAPing the escape of tumor cell growth arrest after chronic PI3K/mTOR inhibition.

Georgios D Vavougios1, Sotirios G Zarogiannis2.   

Abstract

Entities:  

Year:  2017        PMID： 28616313      PMCID： PMC5465112          DOI： 10.21037/jtd.2017.04.35

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  12 in total

1.  A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer.

Authors:  Björn von Eyss; Laura A Jaenicke; Roderik M Kortlever; Nadine Royla; Katrin E Wiese; Sebastian Letschert; Leigh-Anne McDuffus; Markus Sauer; Andreas Rosenwald; Gerard I Evan; Stefan Kempa; Martin Eilers
Journal:  Cancer Cell       Date:  2015-12-14       Impact factor: 31.743

2.  Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer.

Authors:  Weifan Xiao; Jiayi Wang; Chao Ou; Yue Zhang; Lifang Ma; Wenhao Weng; Qiuhui Pan; Fenyong Sun
Journal:  Biochem Biophys Res Commun       Date:  2013-08-28       Impact factor: 3.575

Review 3.  p38 MAPK in development and cancer.

Authors:  Cynthia Bradham; David R McClay
Journal:  Cell Cycle       Date:  2006-04-17       Impact factor: 4.534

Review 4.  Mammalian target of rapamycin: a central node of complex signaling cascades.

Authors:  Yoh Dobashi; Yasutaka Watanabe; Chihiro Miwa; Sakae Suzuki; Shinichiro Koyama
Journal:  Int J Clin Exp Pathol       Date:  2011-06-14

5.  BDNF alters ERK/p38 MAPK activity ratios to promote differentiation in growth plate chondrocytes.

Authors:  Michele R Hutchison
Journal:  Mol Endocrinol       Date:  2012-06-14

6.  The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling.

Authors:  Huan-Tian Zhang; Tao Gui; Yuan Sang; Jie Yang; Yu-Hang Li; Gui-Hong Liang; Thomas Li; Qing-Yu He; Zhen-Gang Zha
Journal:  J Cell Biochem       Date:  2017-04-18       Impact factor: 4.429

7.  ERK and p38 MAPK Activities Determine Sensitivity to PI3K/mTOR Inhibition via Regulation of MYC and YAP.

Authors:  Taru Muranen; Laura M Selfors; Julie Hwang; Lisa L Gallegos; Jonathan L Coloff; Carson C Thoreen; Seong A Kang; David M Sabatini; Gordon B Mills; Joan S Brugge
Journal:  Cancer Res       Date:  2016-10-20       Impact factor: 12.701

8.  mTOR Inhibitors at a Glance.

Authors:  Yin Zheng; Yu Jiang
Journal:  Mol Cell Pharmacol       Date:  2015

9.  Outlook on PI3K/AKT/mTOR inhibition in acute leukemia.

Authors:  Lars Fransecky; Liliana H Mochmann; Claudia D Baldus
Journal:  Mol Cell Ther       Date:  2015-03-20

10.  JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.

Authors:  Haifeng Qiu; Jing Li; Leslie H Clark; Amanda L Jackson; Lu Zhang; Hui Guo; Joshua E Kilgore; Paola A Gehrig; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Oncotarget       Date:  2016-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.